| Patient | Sugar Ray Robinson |
|---|---|
| Date of birth | 1921-05-03 |
| Identifiers | MRN HR-BX003-SYN-TD; SSN (made up) 000-03-9318 |
| Document date | 1984-10-01 |
| Author | Langston Pryce-Okonjo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Nausea, loose stools and dizziness for five days. [S]
Sugar Ray Robinson came in without an appointment with his care partner because of nausea, poor appetite and three or four loose stools a day for five days, with one episode of vomiting yesterday and dizziness when he stands up. Donepezil was raised from 5 mg to 10 mg at bedtime nine days ago; the symptoms began four days later. He has had vivid dreams since the increase. He has kept drinking water but has eaten little, and has kept taking metformin and lisinopril. No fever, blood in the stool, abdominal pain, chest pain or fainting. His home glucose readings have been 100 to 140 mg/dL. Nobody else at home is ill. [S]
| Element | Detail |
|---|---|
| Onset | Five days ago, four days after donepezil was raised to 10 mg |
| Character | Nausea, loose stools, one vomit; dizziness on standing |
| Severity | Moderate; eating little |
| Associated signs and symptoms | Vivid dreams; no fever, blood, abdominal pain, chest pain or fainting |
| Context | Metformin and lisinopril continued; home glucose 100 to 140 mg/dL |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; poor appetite; no fever |
| Gastrointestinal | Positive | Nausea, one vomit, three or four loose stools a day; no blood or abdominal pain |
| Cardiovascular | Positive | Dizzy on standing; no chest pain, palpitations or fainting |
| Neurological | Positive | Vivid dreams; no new confusion beyond his usual memory loss, no weakness |
| Genitourinary | Negative | Passing urine, less than usual |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 1982-03-01 | active | S |
| Glipizide 5 mg oral tablet, one tablet before breakfast | One tablet before breakfast | Oral route | 1983-01-15 to 1984-08-18 | completed | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1981-06-01 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1982-03-01 | active | S |
| Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter | One capsule at bedtime | Oral route | 1983-10-01 to 1984-07-07 | stopped | S |
| Donepezil 5 mg oral tablet, one tablet at bedtime | One tablet at bedtime | Oral route | 1984-08-18 to 1984-09-22 | completed | S |
| Donepezil 10 mg oral tablet, one tablet at bedtime | One tablet at bedtime | Oral route | 1984-09-22 to 1984-10-01 | stopped | S |
| Donepezil 5 mg oral tablet, one tablet each morning with breakfast | One tablet each morning with breakfast | Oral route | 1984-10-01 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1984-10-01 | Body height | 180 | cm | S |
| 1984-10-01 | Body weight | 74.6 | kg | S |
| 1984-10-01 | Body mass index (BMI) [Ratio] | 23 | kg/m2 | S |
| 1984-10-01 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1984-10-01 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1984-10-01 | Heart rate | 56 | /min | S |
| 1984-10-01 | Respiratory rate | 16 | /min | S |
| 1984-10-01 | Body temperature | 36.8 | Cel | S |
| 1984-10-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1984-10-01 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1984-10-01 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1984-10-01 | Creatinine [Mass/volume] in Serum or Plasma | 1.2 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1984-10-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1979)/1.73 sq M | 68 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1984-10-01 | Glucose [Mass/volume] in Serum or Plasma | 112 | mg/dL | 70-140 mg/dL | Normal | S |
Vital signs recorded on 1984-10-01; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired but alert, at his usual level of orientation; temperature 36.8 °C; pulse 56 and regular; blood pressure 118/70 seated and 106/66 standing, with dizziness |
| Mouth | Dry mucous membranes |
| Abdomen | Soft, non-tender, bowel sounds active |
| Cardiovascular | Regular slow rhythm; no murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found | resolved | confirmed | R41.3 | S — Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Alzheimer's disease with early onset, confirmed by a positive amyloid PET, with an amnestic presentation; traumatic encephalopathy syndrome, a research diagnosis, considered | active | confirmed | G30.0 | S — Synthetic modern diagnosis by current criteria at the third visit; not a retrospective diagnosis of the historical person beyond the documented Alzheimer's disease. |
| Mild dementia due to Alzheimer's disease (CDR 1, MMSE 22, MoCA 18), without behavioral or psychological symptoms | active | confirmed | F02.A0 | S — Synthetic stage at diagnosis. |
| Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea | active | confirmed | E11.9 | S — Synthetic modern diabetes anchored to his documented diabetes. |
| Hypertension, controlled on lisinopril | active | confirmed | I10 | S — Synthetic modern hypertension anchored to the single press report. |
| Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometry | active | confirmed | H90.3 | S — Synthetic finding checked as a modifiable contributor to cognitive difficulty. |
| Nausea, loose stools, dizziness on standing and a slow pulse (56) nine days after donepezil was raised to 10 mg, with mild dehydration (creatinine 1.2 mg/dL); resolved after returning to 5 mg in the morning and two days of sick-day rules | resolved | confirmed | R11.0 | S — Synthetic adverse effect of a cholinesterase inhibitor; not a historical claim. |
Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); 13. Older Adults: Standards of Care in Diabetes-2026 (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023)
Follow-up: Nurse phone call tomorrow and in two days. Sixteen-week review in four weeks with potassium and creatinine. Next scheduled visit 1984-10-27: sixteen-week review: medicines, kidneys, mood, caregiver strain and the plan. [S]